oxsoralen
italfarmaco s.p.a. - metoxalene - metoxalene
uvadex
therakos europe limited - metoxalene - metoxalene
metoxsalene g.l. pharma
g.l. pharma gmbh - altre citochine e immunomodulatori - altre citochine e immunomodulatori
metoxsalene s.a.l.f.
s.a.l.f. spa laboratorio farmacologico - altre citochine e immunomodulatori - altre citochine e immunomodulatori
furosemide aurobindo
aurobindo pharma (italia) s.r.l. - furosemide - furosemide
teysuno
nordic group b.v. - tegafur, gimeracil, oteracil - neoplasie dello stomaco - agenti antineoplastici - teysuno is indicated in adults:- for the treatment of advanced gastric cancer when given in combination with cisplatin (see section 5. - as monotherapy or in combination with oxaliplatin or irinotecan, with or without bevacizumab, for the treatment of patients with metastatic colorectal cancer for whom it is not possible to continue treatment with another fluoropyrimidine due to hand-foot syndrome or cardiovascular toxicity that developed in the adjuvant or metastatic setting.
durogesic matrix 25 ug/h cerotto transdermico
janssen-cilag ag - fentanylum - cerotto transdermico - fentanylum 4.2 mg, acrylates et vinylis acetatis polymerisatum, trägermaterial: polyesterum, ethyleni et vinylis acetatis polymerisatum, drucktinte: rot, ad praeparationem pro 10.5 cm² cum liberatione 25 µg/h. - analgesico - synthetika
durogesic matrix 50 ug/h cerotto transdermico
janssen-cilag ag - fentanylum - cerotto transdermico - fentanylum 8.4 mg, acrylates et vinylis acetatis polymerisatum, trägermaterial: polyesterum, ethyleni et vinylis acetatis polymerisatum, drucktinte: grün, ad praeparationem pro 21 cm² cum liberatione 50 µg/h. - analgesico - synthetika
durogesic matrix 75 ug/h cerotto transdermico
janssen-cilag ag - fentanylum - cerotto transdermico - fentanylum 12.6 mg, acrylates et vinylis acetatis polymerisatum, trägermaterial: polyesterum, ethyleni et vinylis acetatis polymerisatum, drucktinte: blau, ad praeparationem pro 31.5 cm² cum liberatione 75 µg/h. - analgesico - synthetika